F
Félix Gutiérrez
Researcher at Universidad Miguel Hernández de Elche
Publications - 321
Citations - 10243
Félix Gutiérrez is an academic researcher from Universidad Miguel Hernández de Elche. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 48, co-authored 302 publications receiving 8638 citations. Previous affiliations of Félix Gutiérrez include Hospital General Universitario Gregorio Marañón & Carlos III Health Institute.
Papers
More filters
Journal ArticleDOI
Increased risk of non-AIDS-related events in HIV subjects with persistent low CD4 counts despite cART in the CoRIS cohort.
Yolanda M. Pacheco,Inmaculada Jarrín,Isaac Rosado,Antoni Campins,Juan Berenguer,José Antonio Iribarren,Maria Romina Rivero,L Muñoz-Medina,Enrique Bernal-Morell,Félix Gutiérrez,Manuel Leal,CoRIS +11 more
TL;DR: The results stress the need to control accelerated aging in HIV-infected subjects who persistently maintain low CD4 levels despite virological response to cART in the Spanish CoRIS cohort to counter their increased risk of non-AIDS-defining diseases, particularly cancer.
Journal ArticleDOI
Patients' characteristics and clinical implications of suboptimal CD4 T-cell gains after 1 year of successful antiretroviral therapy.
Félix Gutiérrez,Sergio Padilla,Mar Masiá,José Antonio Iribarren,Santiago Moreno,Pompeyo Viciana,José Hernández-Quero,Remedios Aleman,Francesc Vidal,Miguel Salavert,José Ramón Blanco,Manuel Leal,Fernando Dronda,Santiago Perez Hoyos,Julia del Amo,CoRIS-MD +15 more
TL;DR: In patients with sustained virological suppression with CART, previous injection drug use, but not hepatitis C virus coinfection, and older age at initiation of therapy were associated with suboptimal CD4 T-cell responses.
Journal ArticleDOI
Simeprevir (TMC435) With Pegylated Interferon/Ribavirin in Patients Coinfected With HCV Genotype 1 and HIV-1: A Phase 3 Study
Douglas T. Dieterich,Jürgen K. Rockstroh,Chloe Orkin,Félix Gutiérrez,Marina B. Klein,Jacques Reynes,Umesh Shukla,Alan Jenkins,Oliver Lenz,Sivi Ouwerkerk-Mahadevan,Monika Peeters,Guy De La Rosa,Lotke Tambuyzer,W. Jessner +13 more
TL;DR: Simeprevir was generally well tolerated with safety similar to that observed inHCV-monoinfected patients and high SVR12 rates in HCV treatment-naive patients, prior relapsers, prior partial responders, and prior null responders with HIV-1 coinfection.
Journal ArticleDOI
Decrease in serial prevalence of coinfection with hepatitis C virus among HIV-infected patients in Spain, 1997-2006.
Santiago Pérez Cachafeiro,Julia del Amo,José Antonio Iribarren,Miguel Salavert Lleti,Félix Gutiérrez,Ana Moreno,Pablo Labarga,Juan A. Pineda,Francesc Vidal,Juan Berenguer,Santiago Moreno,CoRIS-MD +11 more
TL;DR: The prevalence of injection drug use and coinfection among Spanish patients infected with human immunodeficiency virus and hepatitis C virus decreased, caused by a change in transmission routes of HIV infection.